Sino Medical Sciences Technology Inc. (SHA:688108)
China · Delayed Price · Currency is CNY 21.85
+1.51 (7.42%)
Apr 1, 2026, 3:00 PM CST
SHA:688108 Revenue
In the year 2025, Sino Medical Sciences Technology had annual revenue of 525.41M CNY with 14.53% growth. Sino Medical Sciences Technology had revenue of 161.55M in the quarter ending December 31, 2025, with 15.19% growth.
Revenue
525.41M
Revenue Growth
+14.53%
P/S Ratio
17.38
Revenue / Employee
760.36K
Employees
113
Market Cap
9.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 525.41M | 66.67M | 14.53% |
| Dec 31, 2024 | 458.74M | 115.48M | 33.64% |
| Dec 31, 2023 | 343.26M | 150.40M | 77.99% |
| Dec 31, 2022 | 192.85M | -1.50M | -0.77% |
| Dec 31, 2021 | 194.36M | -133.06M | -40.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shinva Medical Instrument | 9.58B |
| Sinocare | 4.71B |
| Guangzhou Wondfo Biotech Co.,Ltd | 2.57B |
| Qingdao Haier Biomedical Co.,Ltd | 2.33B |
| Edan Instruments | 1.90B |
| INKON Life Technology | 1.89B |
| Shenzhen YHLO Biotech | 1.81B |
| Beijing Wandong Medical Technology | 1.35B |